Overview

Efficacy Maxinom® And Maxitrol® in Reducing The Signs And Symptoms Of Acute Bacterial Conjunctivitis

Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to evaluate, through clinical parameters, the effectiveness of your medicine topic Maxinom ® (dexamethasone, neomycin and polymyxin B - Union Chemicals), comparing it to the topical medication Maxitrol ® (dexamethasone, neomycin and polymyxin B - Alcon ) by the percentage of improvement (sustained response rate) at the end of treatment, among the products studied.
Phase:
Phase 3
Details
Lead Sponsor:
Azidus Brasil
Treatments:
Bacitracin
Bacitracin zinc, neomycin sulfate, polymyxin B, drug combination
BB 1101
Dexamethasone
Dexamethasone 21-phosphate
Dexamethasone acetate
Dexamethasone, neomycin, polymyxin B drug combination
Fluprednisolone
Neomycin
Polymyxin B
Polymyxins